X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with ASTRAZENECA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ASTRAZENECA PHARMA SHASUN PHARMA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 123.9 92.1 134.6% View Chart
P/BV x 8.5 13.1 65.1% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHASUN PHARMA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ASTRAZENECA PHARMA
Mar-14
SHASUN PHARMA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs941,285 7.3%   
Low Rs46634 7.2%   
Sales per share (Unadj.) Rs214.2189.6 113.0%  
Earnings per share (Unadj.) Rs5.3-0.2 -2,620.8%  
Cash flow per share (Unadj.) Rs15.83.8 411.5%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.368.6 77.7%  
Shares outstanding (eoy) m56.6225.00 226.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.35.1 6.4%   
Avg P/E ratio x13.1-4,712.7 -0.3%  
P/CF ratio (eoy) x4.4249.6 1.8%  
Price / Book Value ratio x1.314.0 9.4%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,95823,988 16.5%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m2,1641,605 134.8%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m12,1274,740 255.9%  
Other income Rs m22992 249.0%   
Total revenues Rs m12,3564,832 255.7%   
Gross profit Rs m1,009-130 -777.4%  
Depreciation Rs m594101 586.6%   
Interest Rs m4150-   
Profit before tax Rs m230-139 -165.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m-735 -1,428.7%   
Profit after tax Rs m302-5 -5,935.6%  
Gross profit margin %8.3-2.7 -303.8%  
Effective tax rate %-31.7-3.7 863.9%   
Net profit margin %2.5-0.1 -2,319.9%  
BALANCE SHEET DATA
Current assets Rs m6,8842,726 252.5%   
Current liabilities Rs m8,4562,435 347.3%   
Net working cap to sales %-13.06.1 -210.8%  
Current ratio x0.81.1 72.7%  
Inventory Days Days6274 83.6%  
Debtors Days Days10841 263.9%  
Net fixed assets Rs m4,9701,035 480.1%   
Share capital Rs m11350 226.6%   
"Free" reserves Rs m2,875942 305.1%   
Net worth Rs m3,0201,716 176.0%   
Long term debt Rs m1,8170-   
Total assets Rs m13,3474,156 321.2%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.91.1 79.7%   
Return on assets %5.4-0.1 -4,387.6%  
Return on equity %10.0-0.3 -3,372.4%  
Return on capital %13.30-  
Exports to sales %46.45.7 813.1%   
Imports to sales %14.26.5 220.5%   
Exports (fob) Rs m5,622270 2,080.5%   
Imports (cif) Rs m1,728306 564.1%   
Fx inflow Rs m5,843375 1,559.7%   
Fx outflow Rs m2,173470 462.2%   
Net fx Rs m3,669-96 -3,840.4%   
CASH FLOW
From Operations Rs m398-8 -4,908.6%  
From Investments Rs m-1,635-146 1,122.2%  
From Financial Activity Rs m1,309862 151.8%  
Net Cashflow Rs m71709 10.0%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.6 0.3 1,200.0%  
FIIs % 17.6 15.7 112.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 9.1 435.2%  
Shareholders   20,750 12,856 161.4%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   GLENMARK PHARMA  FULFORD INDIA  DR. REDDYS LAB  DIVIS LABORATORIES  UNICHEM LAB  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; Tata Stocks in Focus(09:30 am)

Asian stock indices are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 0.13% while the Hang Seng is down 0.54%. The Shanghai Composite is trading down by 0.02%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS